• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自噬通量受损参与TAT-Cx43对胶质母细胞瘤干细胞的抗肿瘤作用。

Impairment of Autophagic Flux Participates in the Antitumor Effects of TAT-Cx43 in Glioblastoma Stem Cells.

作者信息

Pelaz Sara G, Ollauri-Ibáñez Claudia, Lillo Concepción, Tabernero Arantxa

机构信息

Instituto de Neurociencias de Castilla y León (INCYL), Universidad de Salamanca, Calle Pintor Fernando Gallego 1, 37007 Salamanca, Spain.

Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Campus Miguel de Unamuno, 37007 Salamanca, Spain.

出版信息

Cancers (Basel). 2021 Aug 24;13(17):4262. doi: 10.3390/cancers13174262.

DOI:10.3390/cancers13174262
PMID:34503072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8428230/
Abstract

Autophagy is a physiological process by which various damaged or non-essential cytosolic components are recycled, contributing to cell survival under stress conditions. In cancer, autophagy can have antitumor or protumor effects depending on the developmental stage. Here, we use Western blotting, immunochemistry, and transmission electron microscopy to demonstrate that the antitumor peptide TAT-Cx43, a c-Src inhibitor, blocks autophagic flux in glioblastoma stem cells (GSCs) under basal and nutrient-deprived conditions. Upon nutrient deprivation, GSCs acquired a dormant-like phenotype that was disrupted by inhibition of autophagy with TAT-Cx43 or chloroquine (a classic autophagy inhibitor), leading to GSC death. Remarkably, dasatinib, a clinically available c-Src inhibitor, could not replicate TAT-Cx43 effect on dormant GSCs, revealing for the first time the possible involvement of pathways other than c-Src in TAT-Cx43 effect. TAT-Cx43 exerts an antitumor effect both in nutrient-complete and nutrient-deprived environments, which constitutes an advantage over chloroquine and dasatinib, whose effects depend on nutrient environment. Finally, our analysis of the levels of autophagy-related proteins in healthy and glioma donors suggests that autophagy is upregulated in glioblastoma, further supporting the interest in inhibiting this process in the most aggressive brain tumor and the potential use of TAT-Cx43 as a therapy for this type of cancer.

摘要

自噬是一种生理过程,通过该过程各种受损或非必需的胞质成分被循环利用,有助于细胞在应激条件下存活。在癌症中,自噬根据发育阶段可产生抗肿瘤或促肿瘤作用。在此,我们使用蛋白质免疫印迹法、免疫化学和透射电子显微镜来证明抗肿瘤肽TAT-Cx43(一种c-Src抑制剂)在基础条件和营养缺乏条件下阻断胶质母细胞瘤干细胞(GSCs)的自噬流。在营养缺乏时,GSCs获得一种类似休眠的表型,而用TAT-Cx43或氯喹(一种经典的自噬抑制剂)抑制自噬会破坏这种表型,导致GSC死亡。值得注意的是,达沙替尼(一种临床可用的c-Src抑制剂)不能复制TAT-Cx43对休眠GSCs的作用,首次揭示了除c-Src外的其他途径可能参与TAT-Cx43的作用。TAT-Cx43在营养充足和营养缺乏的环境中均发挥抗肿瘤作用,这是优于氯喹和达沙替尼的一个优势,后两者的作用取决于营养环境。最后,我们对健康和胶质瘤供体中自噬相关蛋白水平的分析表明,胶质母细胞瘤中自噬上调,进一步支持了在这种最具侵袭性的脑肿瘤中抑制这一过程的意义以及TAT-Cx43作为这种癌症治疗方法的潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/2a2c14a41cb0/cancers-13-04262-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/62bae2b72107/cancers-13-04262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/2af83c9d481a/cancers-13-04262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/3462035056d9/cancers-13-04262-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/d0cc9fa0df5e/cancers-13-04262-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/19eeb0fe5d74/cancers-13-04262-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/2a2c14a41cb0/cancers-13-04262-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/62bae2b72107/cancers-13-04262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/2af83c9d481a/cancers-13-04262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/3462035056d9/cancers-13-04262-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/d0cc9fa0df5e/cancers-13-04262-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/19eeb0fe5d74/cancers-13-04262-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb4/8428230/2a2c14a41cb0/cancers-13-04262-g006.jpg

相似文献

1
Impairment of Autophagic Flux Participates in the Antitumor Effects of TAT-Cx43 in Glioblastoma Stem Cells.自噬通量受损参与TAT-Cx43对胶质母细胞瘤干细胞的抗肿瘤作用。
Cancers (Basel). 2021 Aug 24;13(17):4262. doi: 10.3390/cancers13174262.
2
Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43.通过 TAT-Cx43 特异性抑制 c-Src 靶向体外和体内神经胶质瘤干细胞的代谢可塑性
EBioMedicine. 2020 Dec;62:103134. doi: 10.1016/j.ebiom.2020.103134. Epub 2020 Nov 27.
3
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.表皮生长因子受体扩增和 EGFRvIII 预测并参与了 TAT-Cx43266-283 在临床前胶质母细胞瘤模型中的抗肿瘤反应。
Neuro Oncol. 2024 Jul 5;26(7):1230-1246. doi: 10.1093/neuonc/noae060.
4
A c-Src Inhibitor Peptide Based on Connexin43 Exerts Neuroprotective Effects through the Inhibition of Glial Hemichannel Activity.一种基于连接蛋白43的c-Src抑制剂肽通过抑制胶质半通道活性发挥神经保护作用。
Front Mol Neurosci. 2017 Dec 15;10:418. doi: 10.3389/fnmol.2017.00418. eCollection 2017.
5
A proteomic approach supports the clinical relevance of TAT-Cx43 in glioblastoma.一种蛋白质组学方法支持 TAT-Cx43 在神经胶质瘤中的临床相关性。
Transl Res. 2024 Oct;272:95-110. doi: 10.1016/j.trsl.2024.06.001. Epub 2024 Jun 12.
6
Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo.连接蛋白 43 肽,TAT-Cx43266-283,特异性靶向神经胶质瘤细胞,损害恶性生长,并增强体内小鼠模型的存活。
Neuro Oncol. 2020 Apr 15;22(4):493-504. doi: 10.1093/neuonc/noz243.
7
A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK.连接蛋白 43 的短区域通过Src、PTEN 和 FAK 减少人神经胶质瘤干细胞的迁移、侵袭和存活。
Stem Cell Reports. 2017 Aug 8;9(2):451-463. doi: 10.1016/j.stemcr.2017.06.007. Epub 2017 Jul 14.
8
Connexin43 Region 266-283, via Src Inhibition, Reduces Neural Progenitor Cell Proliferation Promoted by EGF and FGF-2 and Increases Astrocytic Differentiation.连接蛋白 43 区 266-283 通过抑制Src,减少 EGF 和 FGF-2 促进的神经前体细胞增殖,并增加星形胶质细胞分化。
Int J Mol Sci. 2020 Nov 23;21(22):8852. doi: 10.3390/ijms21228852.
9
MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.MIR93(microRNA-93)通过靶向自噬调节胶质母细胞瘤的肿瘤发生和治疗反应。
Autophagy. 2019 Jun;15(6):1100-1111. doi: 10.1080/15548627.2019.1569947. Epub 2019 Jan 31.
10
Nutrient starvation induces apoptosis and autophagy in C6 glioma stem-like cells.营养饥饿诱导C6胶质瘤干细胞样细胞发生凋亡和自噬。
Heliyon. 2021 Feb 26;7(2):e06352. doi: 10.1016/j.heliyon.2021.e06352. eCollection 2021 Feb.

引用本文的文献

1
Integrative Analysis the Role of ENG as a Metabolic and Macrophage-Related Gene in Hepatocellular Carcinoma.整合分析ENG作为肝细胞癌中与代谢和巨噬细胞相关基因的作用。
Biochem Genet. 2025 Apr 17. doi: 10.1007/s10528-025-11098-z.
2
Forms of Non-Apoptotic Cell Death and Their Role in Gliomas-Presentation of the Current State of Knowledge.非凋亡性细胞死亡的形式及其在胶质瘤中的作用——当前知识现状介绍
Biomedicines. 2024 Jul 11;12(7):1546. doi: 10.3390/biomedicines12071546.
3
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.

本文引用的文献

1
Autophagy and Cancer Dormancy.自噬与癌症休眠
Front Oncol. 2021 Mar 19;11:627023. doi: 10.3389/fonc.2021.627023. eCollection 2021.
2
Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43.通过 TAT-Cx43 特异性抑制 c-Src 靶向体外和体内神经胶质瘤干细胞的代谢可塑性
EBioMedicine. 2020 Dec;62:103134. doi: 10.1016/j.ebiom.2020.103134. Epub 2020 Nov 27.
3
The promoting role of lysosome-localized c-Src in autophagosome-lysosome fusion.溶酶体定位的c-Src在自噬体-溶酶体融合中的促进作用。
表皮生长因子受体扩增和 EGFRvIII 预测并参与了 TAT-Cx43266-283 在临床前胶质母细胞瘤模型中的抗肿瘤反应。
Neuro Oncol. 2024 Jul 5;26(7):1230-1246. doi: 10.1093/neuonc/noae060.
4
Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer.靶向三阴性乳腺癌中的 NANOG 和 FAK 的 Cx26 衍生穿膜肽。
Mol Cancer Ther. 2024 Jan 3;23(1):56-67. doi: 10.1158/1535-7163.MCT-21-0783.
5
ALA-A2 Is a Novel Anticancer Peptide Inspired by Alpha-Lactalbumin: A Discovery from a Computational Peptide Library, In Silico Anticancer Peptide Screening and In Vitro Experimental Validation.ALA-A2是一种受α-乳白蛋白启发的新型抗癌肽:来自计算肽库、计算机辅助抗癌肽筛选及体外实验验证的一项发现。
Glob Chall. 2023 Jan 12;7(3):2200213. doi: 10.1002/gch2.202200213. eCollection 2023 Mar.
6
Src: coordinating metabolism in cancer.Src:协调癌症中的代谢。
Oncogene. 2022 Nov;41(45):4917-4928. doi: 10.1038/s41388-022-02487-4. Epub 2022 Oct 10.
Cell Signal. 2020 Nov;75:109774. doi: 10.1016/j.cellsig.2020.109774. Epub 2020 Sep 8.
4
Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial.氯喹联合同期放疗和替莫唑胺治疗新诊断的胶质母细胞瘤:一项 Ib 期试验。
Autophagy. 2021 Sep;17(9):2604-2612. doi: 10.1080/15548627.2020.1816343. Epub 2020 Sep 20.
5
A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.具有四个自噬相关基因的风险特征可预测多形性胶质母细胞瘤的生存。
J Cell Mol Med. 2020 Apr;24(7):3807-3821. doi: 10.1111/jcmm.14938. Epub 2020 Feb 17.
6
Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.基于自噬相关基因表达的风险特征与胶质母细胞瘤患者预后的相关性
Onco Targets Ther. 2020 Jan 7;13:95-107. doi: 10.2147/OTT.S238332. eCollection 2020.
7
Immunohistochemical assessment of autophagic protein LC3B and p62 levels in glioma patients.对胶质瘤患者自噬蛋白LC3B和p62水平的免疫组织化学评估。
Int J Clin Exp Pathol. 2018 Feb 1;11(2):862-868. eCollection 2018.
8
Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo.连接蛋白 43 肽,TAT-Cx43266-283,特异性靶向神经胶质瘤细胞,损害恶性生长,并增强体内小鼠模型的存活。
Neuro Oncol. 2020 Apr 15;22(4):493-504. doi: 10.1093/neuonc/noz243.
9
Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients.自噬在癌症中的作用:从机制理解到改善患者治疗反应。
Cell Death Differ. 2020 Mar;27(3):843-857. doi: 10.1038/s41418-019-0474-7. Epub 2019 Dec 13.
10
Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy.针对 PI3K/AKT/mTOR 介导的自噬进行肿瘤治疗。
Appl Microbiol Biotechnol. 2020 Jan;104(2):575-587. doi: 10.1007/s00253-019-10257-8. Epub 2019 Dec 12.